Medical devices, healthcare technology and the business of care
FDA RECALL RECORD · Z-2262-2026

Brand Name: Exacta Mix Product Name: Vented Micro-Volume Inlet Recall

Brand Name: Exacta Mix Product Name: Vented Micro-Volume Inlet Model/Catalog Number: H938175 Product Description: Tubing sets with push-on connector on one end (to attach to the Fluid Selector Valve) and a spike or other appropriate connector on the opposite end to attach the source container.

FDA recall Class II

Ongoing

FDA lists this Class II recall for Brand Name: Exacta Mix Product Name: Vented Micro-Volume Inlet. Review the affected identifiers, reported reason and manufacturer instructions below.

Recall at a glance

Recall number
Z-2262-2026
Recall classification
Class II
Enforcement status
Ongoing
Initiation date
Apr 22, 2026
FDA report date
Jun 10, 2026
Quantity in commerce
105675
Distribution
See key details
FDA cause
Under Investigation by firm

What is being recalled?

Brand Name: Exacta Mix Product Name: Vented Micro-Volume Inlet Model/Catalog Number: H938175 Product Description: Tubing sets with push-on connector on one end (to attach to the Fluid Selector Valve) and a spike or other appropriate connector on the opposite end to attach the source container.

Affected model & UDI checker

Search the exact identifiers published for Z-2262-2026.

The lookup covers structured identifiers listed on this page. A full UDI may also contain lot or serial information; a GTIN match alone does not check those conditions.

Affected products

Model / catalog numberProductLot scope reportedUDI / GTIN
H938175Brand Name: Exacta Mix Product Name: Vented Micro-Volume InletCheck source noticeNot specified
Not specifiedBrand Name: Exacta Mix Product Name: Vented Micro-Volume InletCheck source notice00085412475806
FDA code information

Lot Code: Lot numbers: 804084, 804088, and 804089 UDI Number: 00085412475806

View the original FDA recall notice

Why was this product recalled?

Affected lots may contain incorrect 0.8-micron filters. Use of a 0.8-micron filter in place of the validated 3-micron filter may lead to reduced flow efficiency, incomplete or slower transfers of ingredients, or system alarms. This issue may lead to clinical effects such as electrolyte imbalance, metabolic instability, delayed recovery, etc.

What actions did Baxter Healthcare Corporation take?

On April 22, 2026, the firm began notifying consignees via letters titled URGENT PRODUCT RECALL. Customers were instructed to locate impacted product. Customers may choose to inspect impacted inlets and continue to use those with the correct 3-micron filter, or they may choose to discard impacted inlet lots without inspection and product will be replaced.

Read the manufacturer action recorded by FDA

Recall timeline

  1. Recall initiated by firm

  2. FDA notice posted

  3. FDA classification recorded

  4. FDA enforcement report date

Related FDA submissions

No submission number with an exact verified relationship is linked in the retrieved recall notice.

FDA’s notice explicitly links the submission numbers shown here. Read each filing for its own recorded device and scope.

Source and update history

  1. FDA enforcement data

    First stored snapshot of this source.

  2. FDA device-recall notice

    First stored snapshot of this source.

The history starts with the versions held by MedtechLedger. Earlier source changes are not reconstructed. Official dates and recorded status come from FDA; page summaries describe the source information.

Our data sources and methodology